Active Pulmonary Tuberculosis During Interferon Beta-1a Therapy in a Child with Multiple Sclerosis: A Case Report
Pakize Cennetoğlu, Zeynep Öz, Canan Caymaz, Peren Perk Yücel, Pınar Arıcan, İhsan Kafadar
Cam and Sakura Medical Journal · 2023-01
Abstract
Beta interferons are the first class of disease-modifying therapies, and their immunomodulatory effects are achieved by inhibiting T-cell activation and proliferation. However, modulation and interference with the patient's immune system may lead to adverse effects, such as increased susceptibility to infections.
MeSH terms
- Multiple sclerosis
- Medicine
- Interferon beta-1b
- Interferon beta
- BETA (programming language)
- Tuberculosis
- Pulmonary tuberculosis
- Immunology
- Pediatrics